[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100541024":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":33,"centralContacts":37,"locations":46,"responsibleParty":58,"collaborators":32,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":32,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":71,"enrollmentInfo":72,"targetDuration":32,"studyType":75,"phases":76,"briefSummary":78,"conditions":79,"keywords":32,"overallStatus":81,"whyStopped":32,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Sana'a University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"scaling and root planning with Hyaluronic acid application","EXPERIMENTAL","patients will receive Hyaluronic acid topical gel after scaling and root planning at first week and receive the gel after one week",[13,14],"Drug: Hyaluronic acid","Behavioral: scaling and root planning",{"label":16,"type":10,"description":17,"interventionNames":18},"scaling and root planning only","patients will receive scaling and root planning only",[14],[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Hyaluronic acid","Gengigel syringe containing 1ml of 0.8% HA",[9],[26],"HA syringe",{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"BEHAVIORAL","scaling and root planning","scaling and root planning using ultrasonic scaler",[16,9],null,[34],{"name":35,"affiliation":5,"role":36},"Ghada Almuqayad, BDS","PRINCIPAL_INVESTIGATOR",[38,42],{"name":35,"role":39,"phone":40,"phoneExt":32,"email":41},"CONTACT","+967733855972","Ghadamqd@gmail.com",{"name":43,"role":39,"phone":44,"phoneExt":32,"email":45},"Wadhah Al-haj, Ass prof","+967773446446","Waddah.alhaj@gmail.com",[47],{"facility":48,"status":32,"city":49,"state":32,"zip":32,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":32},"Sana'a university","Sanaa","Yemen","YE",{"type":53,"coordinates":54},"Point",[55,56],44.20646,15.35452,{"lat":56,"lon":55},{"type":36,"investigatorFullName":59,"investigatorTitle":60,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"ghada almuqayad","Principal Investigator,","100541024","clinical-and-immunological-evaluation-of-ha-in-treatment-of-periodontitis-100541024",false,"NCT06324474","Clinical and Immunological Evaluation of HA in Treatment of Periodontitis","Clinical and Immunological Evaluation of Hyaluronic Acid Topical Application in Non-surgical Treatment of Periodontitis","Inclusion Criteria:\n\n* systemically healthy.\n* at least 20 teeth and suffers from moderate \\\u003C7mm to severe. \\>8mm.periodontitis with probing depth \\>5m and in the contralateral side.\n* ability to attend to the clinic in a regular manner.\n\nExclusion Criteria:\n\n* allergy to HA.\n* Chronic disease.\n* orthodontic treatment.\n* Qat chewer and smokers.\n* antibiotic in previous 3 months.\n* supplements and mouthwash.",true,"ALL","20 Years","60 Years",{"count":73,"type":74},24,"ESTIMATED","INTERVENTIONAL",[77],"NA","To evaluate the immunological effectiveness of Hyaluronic acid as adjunction treatment to scaling and root planning and scaling and root planning alone.\n\nComparison between clinical measurement before and after treatment. Evaluate the level of IGF-1 in treated site as immunological marker if periodontal regeneration.",[80],"Periodontitis","NOT_YET_RECRUITING","2024-12-03",{"date":84,"type":85},"2024-12-05","ACTUAL",{"date":87,"type":74},"2025-04",{"date":89,"type":74},"2025-12-12",{"name":5,"class":6},1]